FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

377434003: Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3501705012 Acetaminophen 325 mg and propoxyphene napsylate 50 mg oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3681586010 Dextropropoxyphene napsylate 50 mg and paracetamol 325 mg oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3681587018 Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
105048201000001111 Paracetamol + propoxyphene napsylate 325mg/50mg tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Is a Product containing dextropropoxyphene false Inferred relationship Existential restriction modifier
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Is a Product containing paracetamol false Inferred relationship Existential restriction modifier
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has active ingredient Non-opioid analgesic false Inferred relationship Existential restriction modifier
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has active ingredient Opiate agonist (substance) false Inferred relationship Existential restriction modifier
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has active ingredient Dextropropoxyphene false Inferred relationship Existential restriction modifier
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has active ingredient Paracetamol false Inferred relationship Existential restriction modifier
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Is a Product containing paracetamol and propoxyphene napsylate false Inferred relationship Existential restriction modifier
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has active ingredient Central nervous system agent false Inferred relationship Existential restriction modifier
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has active ingredient Substance with opioid receptor agonist mechanism of action false Inferred relationship Existential restriction modifier
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has active ingredient Dextropropoxyphene napsylate false Inferred relationship Existential restriction modifier
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Is a Product containing paracetamol in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has active ingredient Paracetamol false Inferred relationship Existential restriction modifier 1
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has basis of strength substance Paracetamol true Inferred relationship Existential restriction modifier 1
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has presentation strength numerator value 325 false Inferred relationship Existential restriction modifier 1
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has active ingredient Dextropropoxyphene napsylate false Inferred relationship Existential restriction modifier 2
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has basis of strength substance Dextropropoxyphene napsylate true Inferred relationship Existential restriction modifier 2
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has presentation strength numerator value 50 false Inferred relationship Existential restriction modifier 2
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 2
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 2
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 2
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has unit of presentation Tablet true Inferred relationship Existential restriction modifier
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has precise active ingredient Paracetamol true Inferred relationship Existential restriction modifier 1
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Has precise active ingredient Dextropropoxyphene napsylate true Inferred relationship Existential restriction modifier 2
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Is a Product containing dextropropoxyphene and paracetamol false Inferred relationship Existential restriction modifier
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely dextropropoxyphene napsylate 50 milligram and paracetamol 325 milligram/1 each conventional release oral tablet Is a Product containing only dextropropoxyphene and paracetamol in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start